Clinical Trial Update: Mechanism of SGLT2 Inhibition in the Kidney [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update from the University of Michigan describing a study to investigate the mechanism of SGLT2 inhibition in the kidney for individual…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: University of Michigan | Conditions: Type 2 Diabetes, Diabetic Kidney Disease | Phase 4 | Status: RECRUITING